These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]
13. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697 [TBL] [Abstract][Full Text] [Related]
14. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty. Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120 [TBL] [Abstract][Full Text] [Related]
16. Utilization of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction in a tertiary referral medical center in a developing country. Abdallah M; Karrowni W; Dakik HA Int J Cardiol; 2007 Jan; 114(2):282-3. PubMed ID: 16581145 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V. Ferreira D Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168 [No Abstract] [Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes. Elmouchi DA; Bates ER Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523 [TBL] [Abstract][Full Text] [Related]